RESPeRATE
PrivateLast Round
IPO
Jul 31, 2007
Est. Valuation
$66M
Total Funding Raised
$12.9M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
RESPeRATE is a medical device company that provides an FDA-cleared, non-drug device for lowering blood pressure through patented, device-guided breathing technology.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, D2C Brands, Home & Lifestyle
Business Model
B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RESPeRATE Comparables
Compare RESPeRATE with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HeartMath | 77% | |
| AliveCor | 70% | |
| Lief Therapeutics | 66% |
RESPeRATE Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Jul 31, 2007 | ||||
| Series C | Apr 14, 2005 | ||||
| Series B | Oct 30, 2001 | ||||
| Series A | Jan 5, 2000 |
RESPeRATE Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| I.B.I. - Managing & Underwriting Ltd. | IPO |
| 日本ベンチャーキャピタル株式会社 | Series C |
| Paladin Capital Group | Series B |
| Palladin Consumer Retail Partners | IPO |
| Ant Capital Partners | Series C |
| Medica Venture Partners | IPO, Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2026
Monthly visitors grew 39% MoM, reaching 39.8K.
- Jul 31, 2007
$16M raised with I.B.I. as lead investor.
RESPeRATE Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about RESPeRATE's valuation, stock price, and market status.
Is RESPeRATE a public or private company?
RESPeRATE is a private company.
What is the current stock price of RESPeRATE?
RESPeRATE is a private company with no public stock price. No recent secondary market data is available.
How much is RESPeRATE worth (valuation)?
RESPeRATE's valuation is estimated at $66.0M based on funding round data.
Can I buy RESPeRATE stock?
RESPeRATE shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was RESPeRATE's last funding round?
RESPeRATE's most recent funding round was IPO on July 31, 2007.
Who are the main investors in RESPeRATE?
Key investors in RESPeRATE include I.B.I. - Managing & Underwriting Ltd., 日本ベンチャーキャピタル株式会社, Ant Capital Partners, Medica Venture Partners.
Will RESPeRATE IPO soon?
No public IPO plans have been announced for RESPeRATE.
How can I track RESPeRATE secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor RESPeRATE's secondary market activity and sign up for updates.